Description
A compound of blood plasma proteins, primarily albumin, with glucose formed as a result of non-enzymatic processes and reflecting blood glucose levels over the past 2-3 weeks. The test is used for monitoring diabetes mellitus in cases where glycemic levels cannot be correctly determined by glycated hemoglobin, or for intermediate quarterly assessment of glycemia in diabetic patients.
Period of execution
Within 5 days. The specified time does not include the day of biomaterial collection
Biomaterial type